Advertisement

Citations to this article

Abstract

Persistently activated or tyrosine-phosphorylated STAT3 (pSTAT3) is found in 50% of lung adenocarcinomas. pSTAT3 is found in primary adenocarcinomas and cell lines harboring somatic-activating mutations in the tyrosine kinase domain of EGFR. Treatment of cell lines with either an EGFR inhibitor or an src kinase inhibitor had no effect on pSTAT3 levels, whereas a pan-JAK inhibitor (P6) blocked activation of STAT3 and inhibited tumorigenesis. Cell lines expressing these persistently activated mutant EGFRs also produced high IL-6 levels, and blockade of the IL-6/gp130/JAK pathway led to a decrease in pSTAT3 levels. In addition, reduction of IL-6 levels by RNA interference led to a decrease in tumorigenesis. Introduction of persistently activated EGFR into immortalized breast epithelial cells led to tumorigenesis, IL-6 expression, and STAT3 activation, all of which could be inhibited with P6 or gp130 blockade. Furthermore, inhibition of EGFR activity in multiple cell lines partially blocked transcription of IL-6 and concurrently decreased production and release of IL-6. Finally, immunohistochemical analysis revealed a positive correlation between pSTAT3 and IL-6 positivity in primary lung adenocarcinomas. Therefore, mutant EGFR could activate the gp130/JAK/STAT3 pathway by means of IL-6 upregulation in primary human lung adenocarcinomas, making this pathway a potential target for cancer treatment.

Authors

Sizhi Paul Gao ... Bayard Clarkson, Jacqueline F. Bromberg

×

Total citations by year in Crossref

Year: 2015 2014 2013 2012 2011 2010 2009 2008 2007 Total
Citations: 1 32 25 24 19 19 26 11 1 158
Citation information

Citations to this article in Crossref (158)

Title and authors Publication Year
Genetics and biomarkers in personalisation of lung cancer treatment
R Rosell, TG Bivona, N Karachaliou
The Lancet 2013
Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms
E Elinav, R Nowarski, CA Thaiss, B Hu, C Jin, RA Flavell
Nature Reviews Cancer 2013
New insights for IL-6 targeted therapy as an adjuvant treatment for non-small-cell lung cancer
P Zarogoulidis, L Yarmus, K Zarogoulidis
Therapeutic Delivery 2013
gp130: a promising drug target for cancer therapy
S Xu, N Neamati
Expert Opinion on Therapeutic Targets 2013
Molecular mechanism underlying the antiproliferative effect of suppressor of cytokine signaling-1 in non-small-cell lung cancer cells
K Shimada, S Serada, M Fujimoto, S Nomura, R Nakatsuka, E Harada, K Iwahori, I Tachibana, T Takahashi, A Kumanogoh, T Kishimoto, T Naka
Cancer Science 2013
STAT3 expression correlates with prognosis of thymic epithelial tumors
C Li, Z Wang, Y Liu, P Wang, R Zhang
Journal of Cardiothoracic Surgery 2013
Metastasis suppressor Nm23-H1 inhibits STAT3 signaling via a negative feedback mechanism
L Gong, L Guo, L Li, R Zhao, D Zhu, Q Zhou, Z Wu
Biochemical and Biophysical Research Communications 2013
Dysfunctional endothelial cells directly stimulate cancer inflammation and metastasis: Dysfunctional endothelium stimulates metastasis
JW Franses, NC Drosu, WJ Gibson, VC Chitalia, ER Edelman
International Journal of Cancer 2013
EGFR inhibitor BIBU induces apoptosis and defective autophagy in glioma cells
R Ghildiyal, D Dixit, E Sen
Molecular Carcinogenesis 2012
Involvement of STAT3, NF-κB and associated downstream molecules before and after the onset of urethane induced lung tumors in mouse
M Pandey, KP Gupta
Environmental Toxicology and Pharmacology 2012
Interleukin-6 signaling pathway in targeted therapy for cancer
Y Guo, F Xu, TJ Lu, Z Duan, Z Zhang
Cancer Treatment Reviews 2012
PNAS Plus: STAT3 negatively regulates thyroid tumorigenesis
JP Couto, L Daly, A Almeida, JA Knauf, JA Fagin, M Sobrinho-Simoes, J Lima, V Maximo, P Soares, D Lyden, JF Bromberg
Proceedings of the National Academy of Sciences 2012
ER stress-induced inflammation: does it aid or impede disease progression?
AD Garg, A Kaczmarek, O Krysko, P Vandenabeele, DV Krysko, P Agostinis
Trends in Molecular Medicine 2012
A two-SNP IL-6 promoter haplotype is associated with increased lung cancer risk
J Chen, RY Liu, L Yang, J Zhao, X Zhao, D Lu, N Yi, B Han, XF Chen, K Zhang, J He, Z Lei, Y Zhou, B Pasche, X Li, HT Zhang
Journal of Cancer Research and Clinical Oncology 2012
Overexpression of signal transducer and activator of transcription (STAT-3 and STAT-5) transcription factors and alteration of suppressor of cytokine signaling (SOCS-1) protein in prostate cancer
N Singh, S Hussain, M Bharadwaj, N Kakkar, SK Singh, RC Sobti
Journal of Receptors and Signal Transduction 2012
STAT3 as a therapeutic target for Epstein-Barr virus (EBV) – associated nasopharyngeal carcinoma
Y Ho, SW Tsao, M Zeng, VW Lui
Cancer Letters 2012
Interferon regulatory factor 7 regulates glioma stem cells via interleukin-6 and Notch signalling
X Jin, SH Kim, HM Jeon, S Beck, YW Sohn, J Yin, JK Kim, YC Lim, JH Lee, SH Kim, SH Kang, X Pian, MS Song, JB Park, YS Chae, YG Chung, SH Lee, YJ Choi, DH Nam, YK Choi, H Kim
Brain 2012
Effect of 5-FU and MTX on the Expression of Drug-resistance Related Cancer Stem Cell Markers in Non-small Cell Lung Cancer Cells
H Yi, HJ Cho, SM Cho, K Jo, JA Park, SH Lee, BJ Chang, JS Kim, HC Shin
Korean Journal of Physiology and Pharmacology 2012
Nardilysin and ADAM proteases promote gastric cancer cell growth by activating intrinsic cytokine signalling via enhanced ectodomain shedding of TNF-α
K Kanda, H Komekado, T Sawabu, S Ishizu, Y Nakanishi, M Nakatsuji, R Akitake-Kawano, M Ohno, Y Hiraoka, M Kawada, K Kawada, Y Sakai, K Matsumoto, M Kunichika, T Kimura, H Seno, E Nishi, T Chiba
EMBO Molecular Medicine 2012
Radioimmunoimaging with Mixed Monoclonal Antibodies of Nude Mice Bearing Human Lung Adenocarcinoma Xenografts
D Duan, SL Li, YQ Zhu, T Zhang, CM Lei, XH Cheng
Asian Pacific Journal of Cancer Prevention 2012
Contribution of Fibroblast and Mast Cell (Afferent) and Tumor (Efferent) IL-6 Effects within the Tumor Microenvironment
HJ Hugo, S Lebret, E Tomaskovic-Crook, N Ahmed, T Blick, DF Newgreen, EW Thompson, ML Ackland
Cancer Microenvironment 2012
Cytotoxic Chemotherapy and CD4+ Effector T Cells: An Emerging Alliance for Durable Antitumor Effects
ZC Ding, G Zhou
Clinical and Developmental Immunology 2012
The role of pseudokinases in cancer
H Zhang, A Photiou, G Arnhild, J Stebbing, G Giamas
Cellular Signalling 2012
Pyruvate Kinase M2 Regulates Gene Transcription by Acting as a Protein Kinase
X Gao, H Wang, JJ Yang, X Liu, ZR Liu
Molecular Cell 2012
Impact of Collection and Storage of Lung Tumor Tissue on Whole Genome Expression Profiling
MB Freidin, N Bhudia, E Lim, AG Nicholson, WO Cookson, MF Moffatt
Journal of Molecular Diagnostics 2012

Advertisement
Advertisement